Another important consideration is the presence of genetic rearrangements of the MYC, BCL2, and BCL6 genes that identifies patients with what is called double- or triple-hit lymphomas (MYC with BCL2 and/or BCL6 rearrangements). This evidence concerns the gene MYC and lymphoma.